Miravo Healthcare™ Announces Second Quarter 2021 Results Release Date and Conference Call Details

Rhea-AI Summary

Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF), operating as Miravo Healthcare, has announced that it will release its second quarter 2021 financial results on August 9, 2021, before market opening. A conference call will occur the same day at 11:00 a.m. ET, led by President & CEO Jesse Ledger, which includes a Q&A session. Miravo focuses on healthcare with a diverse product portfolio, targeting therapeutic areas such as pain, allergy, neurology, and dermatology. The company operates a GMP-compliant facility in Varennes, Québec.

Positive

• Scheduled release of second quarter 2021 financial results, potentially indicating upcoming growth or performance insights.
• Conference call planned for August 9, 2021, providing a platform for management to outline future strategies and financial outlook.

Negative

• None.

MISSISSAUGA, ON, July 26, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its second quarter 2021 financial results before markets open on Monday, August 9, 2021.  

The Company will subsequently hold a conference call the same day, Monday, August 9, 2021 at 11:00 a.m. ET, hosted by Jesse Ledger, Miravo's President & Chief Executive Officer and other senior management.  A question-and-answer session will follow the corporate update.

CONFERENCE CALL DETAILS

DATE: Monday, August 9, 2021

TIME:  11:00 a.m. ET

DIAL-IN NUMBER: 416 764 8688 or 1 888 390 0546

TAPED REPLAY: 416 764 8677 or 1 888 390 0541 / REPLAY PASSCODE: 457561#

The audio webcast can be accessed at:

https://produceredition.webcasts.com/starthere.jsp?ei=1470704&tp_key=267126102f

An archived replay of the webcast will be available by clicking the link above.

About Miravo Healthcare
Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products.  The Company targets several therapeutic areas, including pain, allergy, neurology and dermatology.  The Company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.  Miravo's head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the Company's manufacturing facility is located in Varennes, Québec, Canada.  The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration.  For additional information, please visit www.miravohealthcare.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/miravo-healthcare-announces-second-quarter-2021-results-release-date-and-conference-call-details-301340668.html

SOURCE Nuvo Pharmaceuticals Inc.

FAQ

When will Miravo Healthcare release its second quarter 2021 financial results?

Miravo Healthcare will release its second quarter 2021 financial results on August 9, 2021, before markets open.

What time is the conference call for Miravo Healthcare's financial results?

The conference call for Miravo Healthcare's financial results is scheduled for August 9, 2021, at 11:00 a.m. ET.

Who will host the conference call for Miravo Healthcare?

The conference call will be hosted by Jesse Ledger, President & CEO of Miravo Healthcare.

How can I access the conference call audio for Miravo Healthcare?

The audio webcast for the conference call can be accessed through the provided link on the company's press release.